ArticlePDF Available

Stability-Indicating RP-HPLC Method for Analysis of Paracetamol and Tramadol in a Pharmaceutical Dosage Form

Authors:

Abstract and Figures

A simple, isocratic, rapid and accurate reversed phase high performance liquid chromatography method was developed for the quantitative determination of paracetamol and tramadol in commercial medicinal tablets. The chromatographic separation was achieved on an Intersil C18 (250 mm x 4.6 mm, 5μm) column using water pH 3.4 with orthophosphoric acid: methanol (60:40, v/v) as a mobile phase, and UV detection at 228 nm. The chromatographic resolutions between paracetamol and tramadol were found greater than five. The linear range for paracetamol and tramadol were 20.8–39.0 μg/ml and 2.4–4.5 μg/ ml was obtained with correlation coefficients ≥0.999 for each analyte. The retention time were found to be 2.1 and 3.9 min for tramadol and paracetamol respectively. Paracetamol and tramadol was subjected to stress conditions (hydrolysis (acid, base) oxidation, photolysis and thermal degradation) and the stressed samples were analyzed by use of the method. The major degradation was observed in acid and minor in base, thermal, oxidation and photolysis. The forced degradation studies prove the stability indicating power of the method.
Content may be subject to copyright.
ISSN: 0973-4945; CODEN ECJHAO
E-Journal of Chemistry
http://www.ejchem.net 2012, 9(3), 1347-1356
Stability-Indicating RP-HPLC Method for Analysis of
Paracetamol and Tramadol in a Pharmaceutical
Dosage Form
RAJESH M. KAMBLE* AND SHRAWAN G. SINGH
Department of Chemistry, University of Mumbai, Vidyanagari,
Santacruz (East), Mumbai- 400 098, (MS), India
chemrajkam@yahoo.co.in
Received 19 October 2011; Accepted 30 December 2011
Abstract: A simple, isocratic, rapid and accurate reversed phase high
performance liquid chromatography method was developed for the quantitative
determination of paracetamol and tramadol in commercial medicinal tablets.
The chromatographic separation was achieved on an Inertsil C18 (250 mm x 4.6
mm, 5µm) column using water pH 3.4 with orthophosphoric acid: methanol
(60:40, v/v) as a mobile phase, and UV detection at 228 nm. The
chromatographic resolutions between paracetamol and tramadol were found
greater than five. The linear range for paracetamol and tramadol were
20.839.0 µg/ml and 2.44.5 µg/ ml was obtained with correlation
coefficients ≥0.999 for each analyte. The retention time were found to be 2.1
and 3.9 min for tramadol and paracetamol respectively. Paracetamol and
tramadol was subjected to stress conditions (hydrolysis (acid, base) oxidation,
photolysis and thermal degradation) and the stressed samples were analyzed by
use of the method. The major degradation was observed in acid and minor in
base, thermal, oxidation and photolysis. The forced degradation studies prove
the stability indicating power of the method.
Keywords: Paracetamol, Tramadol, RP-HPLC, Validation, Stress studies.
Introduction
In recent times there has been an increased tendency toward development of stability-
indicating assays13, using the approach to stress testing enshrined in International
conference on harmonization (ICH) guideline Q1A (R2)4. This approach is being extended
to drug combinations to enable accurate and precise quantification of several drugs in the
presence of their degradation products. Paracetamol is chemically 4-hydroxy acetanilide
(Figure 1). It is a weak inhibitor of peripheral cyclooxygenase and its analgesic effects may
arise from inhibition of prostanoid synthesis in the CNS. The antipyretic effects of
paracetamol are due to its action at the level of the hypothalamus to reduce pyrogen-initiated
RAJESH M. KAMBLE
1348
alterations in body temperature by inhibiting prostaglandin synthesis56. Tramadol
hydrochloric (±)-cis-2-(dimethylamino) methyl-1-(3-methoxy-phenyl) cyclohexanol
hydrochloride (Figure 1), a synthetic analogue of codeine, is a centrally acting analgesic
agent7. It has been used since 1977 for the relief of severe physical pain and has been the
most widely sold opioid analgesic drug in the world8. There are many reported methods for
analysis of tramadol913 or paracetamol1417 either alone or in combination with other
drugs1820 in pharmaceutical dosage forms. Very few reports are there on simultaneous
estimation of paracetamol and tramadol. They were determined in human plasma samples
using liquid chromatography (LC-MS)2122. In tablets they were estimated using
spectrophotometry2324, HPTLC2526, GC-MS27 and HPLC2730 methods. Till date, to the best
of our knowledge, no method has been reported in the literature for the stability indicating
assay for these two compounds simultaneously. This manuscript describes the development
and validation, in accordance with ICH guidelines, of rapid, economical, precise and
accurate stability-indicating isocratic reversed-phase HPLC method for analysis of
paracetamol and tramadol in the presence of its degradation products.
Paracetamol Tramadol HCl
Figure 1. Structure of paracetamol and tramadol.
Experimental
Chemicals and reagents
Paracetamol and tramadol reference standards were obtained from sigma Aldrich,
Acetonitrile, methanol, water (HPLC grade), orthophosphoric acid (AR) were obtained from
Merck Ltd.
Stock solutions of paracetamol (65 mg) and tramadol (7.5 mg) were weighed
independently and transferred separately to 100 ml volumetric flask. The drug was dissolved
in methanol and dilution was made to the mark. A mixed standard solution was prepared
from above solution by dissolving 4.0 ml of both stock solution in to 100 ml volumetric
flask and diluted up to the volume with mobile phase to get final concentration of 26.0
µg/ml of paracetamol and 3.0 µg/ml of tramadol.
Instrumentation and Chromatographic conditions
An isocratic HPLC (Thermo Electron Corporation) with pump P-2000, UV/VIS-1000 was
used. The analysis was carried out on Inertsil ODS C18 (250 mm x 4.6 mm, 5 µm), a manual
injector with a 20 µl loop was used for the injection of sample solution and the mobile
phase.
Stability-Indicating RP-HPLC Method for Analysis of Paracetamol
1349
Freshly prepared water adjusted pH 3.4 with orthophosphoric acid and methanol in the
ratio of 60:40 v/v was used as mobile phase. These were filtered through 0.45 µm membrane
filter and sonicated before use. The flow rate of mobile phase was 1.0 ml/min. The column
was maintained at ambient temperature. The detection was carried out by at 228 nm and
runtime was around 8 min.
Preparation of tablet solution
Twenty tablets were accurately weighed and finely powdered. A quantity of powder
equivalent to 65 mg of paracetamol and 7.5 mg of tramadol were transferred to 100 ml
volumetric flask and dissolved in methanol. The solution was filtered through Whatmann
filter paper. From the above solution 4.0 ml was taken and diluted to 100 ml with mobile
phase to give test solution containing 26.0 µg/ml of paracetamol and 3.0 µg/ml of tramadol.
These sample solution were injected six different times.
Results and Discussion
Optimization of chromatographic conditions
The primary objective in developing the present stability-indicating HPLC method was to
achieve resolution between paracetamol and tramadol and its degradation products. The
choice of chromatographic conditions selected was based on symmetry of peak shape and
reduction of chromatographic analysis. The mobile phase consisting of buffer (water
adjusted to pH 3.4 with orthophosphoric acid) and methanol in composition of (60:40 v/v)
was selected. In mobile phase organic solvent was selected because of its favourable UV
transmittance, low viscosity and provides good resolution between two drugs. The water
consisting of buffer helps in obtaining sharp peaks and produces good resolution with
retention time 2.1 and 3.9 min for tramadol and paracetamol respectively. The detection was
carried at 228 nm in UV where both drugs showed good absorbance. The chromatographic
analysis time was less than 8.0 min. Resolution of the two components was around 6.0 with
clear baseline separation was obtained as shown in Figure 2.
Figure 2. Typical chromatogram obtained from tramadol and paracetamol solution.
Forced Degradation Studies
In true sense, ICH guideline Q1AR and the ICH’s Common Technical Document31 suggest
stress testing only of the drug substance. For drug products, however, a definition and
guidelines of ‘Stress Testing (drug product)’ is provided in Q1AR32. In literature there exist
RAJESH M. KAMBLE
1350
many reports where stability-indicating assay has been established by carrying out stress
tests directly on pharmaceutical formulations3338.
In the present study the stress testing was carried out on paracetamol and tramadol
containing pharmaceutical formulation and the degradation was observed when the analyte
was subjected to acid, base, oxidation, photolytic and thermal stress conditions. The drug
substances paracetamol and tramadol under acidic conditions leads to formation of an
unknown degradation peaks at the retention time 4.8 and 6.5 min and in oxidative condition
at 7.8 min. Intentional degradation was attempted to stress conditions of acidic (using 0.1N
HCl), basic degradation (using 0.1N NaOH), oxidative degradation (using 3.0% H2O2),
photolytic degradation (UV degradation) and thermal degradation (heated at 100° C) and to
evaluate the ability of the proposed method to separate paracetamol, tramadol and its
degradation products. Concentration of Paracetamol and tramadol (26.0 µg/ml and 3.0
µg/ml) was used in all the degradation studies. After completion of the degradation
processes, the solutions were neutralized and diluted with mobile phase.
Forced degradation in acidic media was performed by taking 4.0 ml aliquot from stock
solution in 50 ml of round bottom flask, to this 5.0 ml of 0.1 N HCl was added and the
solution was refluxed for 12 hrs and neutralized using same strength of 0.1 N NaOH.
Appropriate aliquot was taken from the above solution and diluted with mobile phase to a
final concentration of 26.0 and 3.0 µg/ml of paracetamol and tramadol.
Forced degradation in basic media was performed by taking 4.0 ml aliquot from stock
solution in 50 ml of round bottom flask, to this 5.0 ml of 0.1 N NaOH added and the solution
was refluxed for 12 hrs and neutralized using same strength of 0.1 N HCl. Appropriate
aliquot was taken from the above solution and diluted with mobile phase to a final
concentration of 26.0 and 3.0 µg/ml of paracetamol and tramadol.
Oxidative degradation was performed by taking 4.0 ml aliquot from stock solution in 50
ml of round bottom flask, to this 5.0 ml of 3% v/v of hydrogen peroxide added and the
solution was refluxed for 12 hrs. The solution was diluted with mobile phase to obtain a
final concentration of 26.0 and 3.0 µg/ml of paracetamol and tramadol.
To study the effect of UV light, the drug powder was exposed to light. Approximately 25
mg of tablet powder was spread on a glass dish in a layer that was less than 2 mm thick and
was prepared in mobile phase. All samples for photostability testing were placed in a UV
light cabinet and which were exposed for 12 hrs resulting in an overall illumination of ≥
210Wh/m2 at 25° C with UV radiation. Following removal of glass dish from the UV light
cabinet, all samples were prepared for analysis as previously described.
To study the effect of temperature, the tablet powder was exposed to dry heat in a
controlled temperature oven at 100° C for 12 hrs.
Stress Degradation of Formulation
Chromatograms obtained from paracetamol and tramadol tablet solution after degradation
under acidic, basic, oxidizing, photolytic and thermal conditions are shown in Figures 37.
In acid (0.1 N hydrochloric acid) degradation study showed 14.52% and 32.82%
degradation for tramadol and paracetamol respectively at reflux temperature after 12 hrs. A
major degradation product was observed at 4.8 and 6.5 min.
Stability-Indicating RP-HPLC Method for Analysis of Paracetamol
1351
The degradation in base (0.1 N sodium hydroxide) was found to be 4.75% and 6.19% for
tramadol and paracetamol respectively at reflux temperature after 12 hrs. No degradation
product was observed.
Oxidative degradation study in 3% hydrogen peroxide gave around 4.74% and 1.15%
degradants at reflux temperature at end of 12 hrs. A degradation product was observed at 7.8
min.
In photolytic, UV degradation the drug degraded was 2.24% and 0.65% of tramadol and
paracetamol for 12 hrs. No degradation peak was obtained.
The thermal study was carried out by exposure of tablet powder to dry heat at 100° C for
12 hrs. There were no degradation peak observed in chromatogram and degradation was
6.50% and 1.68% for tramadol and paracetamol respectively.
The results from force degradation studies are summarized in Table 1.
Figure 3. Representative chromatogram obtained from Acidic degradation (0.1 N HCl).
Figure 4. Representative chromatogram obtained from Basic degradation (0.1 N NaOH).
RAJESH M. KAMBLE
1352
Figure 5. Representative chromatogram obtained from oxidative degradation (3% H2O2).
Figure 6. Representative chromatogram obtained from UV radiation in UV light cabinet.
Figure 7. Representative chromatogram obtained from thermal degradation at 100°C.
Method Validation
The test method was validated for specificity, linearity, precision, accuracy, range, stability
of sample solution and robustness were found to be meeting the predetermined acceptance
criteria. The validated method was found to be specific, linear, precise, accurate and robust
for the assay of paracetamol and tramadol in their tablet dose form. Hence, this method can
be introduced into the use for the assay of paracetamol and tramadol in tablets.
Stability-Indicating RP-HPLC Method for Analysis of Paracetamol
1353
Table 1. Results from analysis of samples from the forced degradation study.
Precision, as % RSD evaluated from the area of paracetamol and tramadol peaks from
six replicated injections of standard solution indicating that the measurement system was
precise for the determination of paracetamol and tramadol in tablets. Also, % RSD of
intraday and interday precisions of the proposed method was determined by estimating the
corresponding responses 6 times on the same day and 6 on another day for same
concentration of paracetamol (26.0 µg/ml) and tramadol (3.0µg/ml). The % RSD for both
intraday and interday was not more than 2.0%.
The accuracy of the method was studied by measuring of recovery after standard addition
method of paracetamol and tramadol at 80, 100, 120 and 150% level. Known amounts of
standard solutions of paracetamol (20.8, 26.0, 31.2 and 39.0 µg/ml) and tramadol (2.4, 3.0,
3.6 and 4.5 µg/ml) were spiked to prequantified sample solutions. The percent recoveries
obtained were between 98.0 to 102% for both samples. These high values indicate that the
method is accurate.
Linearity, the value of correlation coefficient obtained from the linearity studies
(correlation coefficient for paracetamol was 0.99986 and for Tramadol was 0.99974)
indicating that the response was linear for paracetamol and Tramadol peaks over the
concentration range from 20.839.0 µg/ml for paracetamol and 2.44.5 µg/ml for Tramadol.
A calibration curve for each sample was obtained by plotting area response versus
concentration which gave a straight line corresponding to the equation: y = mx + c. The
results showed that good correlation existed between the park area and concentration of the
analytes.
condition
Ret.
time
%
RS
D
%
Degrd.
Ret.
time
%
RS
D
%
Degrd.
Acid
degradation
12 hrs
1.95
0.41
14.52
4.03
0.62
32.82
Significant
degradation
product found at
4.8 and 6.5 min
Basic
degradation
12 hrs
2.07
0.79
4.75
4.06
0.35
6.19
Nodegradation
product formed
Oxidative
degradation
12 hrs
2.18
0.78
4.74
4.00
0.48
1.15
Significant
degradation
productfound at
7.8 min
UV
degradation
12 hrs
2.20
0.76
2.24
3.90
0.67
0.65
No degradation
product formed
Thermal
degradation
12 hrs
1.88
0.32
6.50
4.01
0.39
1.68
No degradation
product formed
RAJESH M. KAMBLE
1354
In the system suitability test of solution containing 26.0 µg/ml of paracetamol and 3.0
µg/ml of tramadol were prepared and injected six times (n=6). The standard and sample
solutions were stored at room temperature and analyzed over the time period of 0 hrs, 12 hrs
and 24 hrs. Then different parameters such as retention time, theoretical plates, tailing factor
and resolution were calculated from the obtained chromatograms. Thus absolute difference
between % assay values was not more than ± 2.0 % compared to the initial values which
were in agreement with the USP requirements. Results from validation are presented in
Table 2.
Table 2. Results from Validation of method.
Parameter
Paracetamol
Tramadol
Linearity coefficient
0.99974
0.99986
Precision %RSD
0.16
0.19
Intermediate Precision % RSD
0.20
0.25
Solution stability % RSD 12 hrs
% RSD 24 hrs
0.25
0.11
0.17
0.36
Retention times Minutes
3.9
2.1
Resolution
6.07
---
Table 3. Results from robustness testing.
Chromatographic
change factor
Variation
Paracetamol
Tramadol
Ret.
time
(%)
RSD
Ret.
time
(%)
RSD
Flow rate (ml/min)
0.8
-0.2
4.82
0.42
2.68
0.28
1.0
0.0
3.90
0.10
2.19
0.14
1.2
+0.2
3.23
0.43
1.79
0.41
Wavelength (nm)
226
-0.2
3.88
0.38
2.16
0.33
228
0.0
3.89
0.13
2.18
0.16
230
+0.2
3.60
0.36
2.14
0.32
Mobile phase
38:62
-0.2
4.01
0.50
2.23
0.31
(Methanol: Buffer)
40:60
0.0
3.89
0.19
2.19
0.28
42:58
+0.2
3.74
0.32
2.09
0.81
Stability-Indicating RP-HPLC Method for Analysis of Paracetamol
1355
As recommended in the ICH guidelines, a robustness assessment was performed during
the development of the analytical procedure. The robustness of the method was investigated
under a variety of conditions including slightly changes of flow rate (1.0 ± 0.2 ml/min),
change in detection wavelength ( 228 ± 2.0 nm), change in composition of mobile phase
methanol : buffer (38:62, 40:60, 42:58). One factor at a time was changed to estimate the
effect. The degree of reproducibility of the results obtained as a result of small deliberate
variations in the method parameters has proven that the method is robust and the data is
summarized in Table 3.
Conclusion
The method developed for quantitative analysis of paracetamol and tramadol is rapid,
accurate, precise, selective and reproducible. The method was completely validated and
satisfactory results were obtained for all the characteristics tested. The major degradation
was obtained in acidic and minor in basic, thermal, oxidative and photolytic stress
conditions. The forced degradation studies prove the stability indicating power of the
method and can be used to assess the stability of paracetamol and tramadol in the bulk drug
and in pharmaceutical dosage forms. The method can be conveniently used for assay of the
pharmaceutical dosage forms containing paracetamol and tramadol in quality control
laboratory.
References
1. Singh S, Singh B, Bahuguna R, Wadhwal L and Saxena R, J. Pharma Biomed.
Anal., 2006, 41, 10371040.
2. Mohammadi A, Haririan I, Rezanour N, Ghiasi L and Walker R B, J. Chromatogr.
A, 2006, 1116, 153157.
3. Ivana I, Ljiljana Z and Mira Z, J Chromatogr. A, 2006, 1119, 209215.
4. International Conference on Harmonization, Q1A (R2) Stability Testing of New
Drug Substances and Products International Conference on Hormonization,
IFPMA, Geneva, 2003.
5. Satoskar R S, Bandarkar S D and Ainapare S S, Pharmacology and
Pharmacotherapeutics., 16th ed., Popular prakashan, Mumbai, 1999, 164.
6. Indian Pharmacopoeia Vol III. Published by The Indian pharmacopoeia
commission, Ghaziabad, 2007, 1516.
7. Grosa G, Grosso E D, Russo R and Allegrone G, J. Pharma Biomed. Anal., 2006,
41, 798803.
8. Lintz W., Barth H, Osterloh G and Schmidt-Bothelt E, Drug Res., 1998, 48,
889899.
9. Krzek J and Starek M, Biomed. Chromatogr., 2004, 18, 589599.
10. Kartinasari W F, Palupi T and Indrayanto G, J. Liq. Chromatogr. Related Tech., 27,
2004, 737744.
11. Wiwin F K, Tini P and Gunawan I, J. Liq. Chromatogr. Related Tech., 2005, 27,
737744.
12. Yalda H A, Faezeh S H, Aboul-Enein Y and Alireza F, J. Chromatogr. B, 2006,
830, 207211.
13. Rajasekhar K K, Shankarananth V, Jyosthna P, Chowdary S P and Reddy D P, J.
Pharm. Res., 2011, 4, 386387.
14. Morelli B and Gowda K, J. Pharm Biomed Anal., 1989, 7, 577584.
15. Lau G S N and Critchley J A J H, J. Pharm. Biomed. Anal., 1994, 12, 15631572.
RAJESH M. KAMBLE
1356
16. Bosch M E, Ruiz Sanchez A J, Sanchez Rojas F and Bosch Ojeda C, J. Pharm.
Biomed. Anal., 2006, 42, 291321.
17. Lakshminarayan K V, Ind. J. Pharm. Sci., 2007, 69, 147149.
18. Sawant R, Bhangale L, Josh R and Lanke P, J. Chem. Metrol., 2010, 4, 2127.
19. Gharge D, and Dhabale P, Int. J. Chem. Anal. Sci., 2010, 1, 5861.
20. Srinivasan K K, Alex J, Shirwaikar A A, Jacob S, Sunil Kumar M R and Prabu S L,
Indian J. Pharm. Sci., 2007, 69, 540545.
21. Zhu T, Ding L, Guo X, Yang L and Wen A, Chromatographia, 2007, 66, 171178.
22. Tan Z, Ouyang D, Zhou G, Wang L, Li Z, Wang D, Chen G, Huang S, Liu Y, Hu D
and Zhou H, Yaowu Fenxi Zazhi, 2005, 25, 795798.
23. Li Y, Wan X, Wang G and Cui J, Zhongguo Yaoxue Zazhi (Beijing, China), 2006,
41, 15941595.
24. Narayan S, Kumar P, Sindhu R K, Tiwari A and Ghosh M, Der Pharma Chemica,
2009, 1, 7278.
25. Mary Titus J F, Thenmozhi A, Sridharan D and Palanivelu M, Int. J. Pharma
Recent Res. 2009, 1, 2226.
26. Sam Soloman W D, Vijai Anand P R, Shukla R, Sivakumar R and
Venkatnarayanan R, Int. J. Chem. Tech. Res., 2010, 2, 11881193.
27. Belal T, Awad T and Clark C R, J. Chromatogr. Sci., 2009, 47, 849854.
28. Liu X, Shi J, Liu Y and He Z, Shenyang Yaoke Daxue Xuebao, 2004, 21, 111113.
29. Birajdar A S, Meyyanathan S N and Suresh B, Int. J. Pharmaceuit. Res. Devp.,
2010, 1, 16
30. Kalra K, Naik S, Jarmal G and Mishra N, Int. J. Appl. Chem., 2009, 5, 7376.
31. ICH, The Common Technical Document- QUALITY. International Conference on
Hormonisation, IFPMA, Geneva, 2000
32. ICH, Stability Testing of New Drug Substances and Products. International
Conference on Hormanisation, IFPMA, Geneva, 2000, p.17
33. Garnick R L, Burt G F, Long D A, Bastian J W and Aldred J P, J. Pharm. Sci.,
1984, 73, 7577.
34. Boulton D W, Fawcett J P and Woods D J, Am. J. Health-Syst. Pharm., 1996, 53,
11571161.
35. Montgomery E R, Taylor S, Segretario J, Engler E and Sebastian D, J. Pharm.
Biomed. Anal., 1996, 15, 7382.
36. Zhao Z, Wang Q, Tsai E W, Qin X-Z and Ip D, J. Pharm. Biomed. Anal., 1999, 20,
129136.
37. Kachhadia P K, Doshi A S, Ram V R and Joshi H S, Chromatographia, 2008, 68,
9971001.
38. Shabir G A and Arain S A, J. Liq. Chromatogr. Related Tech., 2011, 34, 719729.
... These combinations are widely used in clinical treatments to overcome pain, headache, fever and other ailments in humans [7][8][9]. Different analytical methods have been used for the separation/determination of paracetamol [10][11][12][13], caffeine [14][15][16], and tramadol 2 of 14 hydrochloride [17,18], or even mixtures of them, such as paracetamol and caffeine [19][20][21][22][23][24] or paracetamol and tramadol hydrochloride [25][26][27][28][29][30][31]. In the majority of these works, a C 18 column for high performance liquid chromatography (HPLC) separation has been the most largely used stationary phase, together with a mobile phase mainly based on acetonitrile at acidic pH and a photodiode-array (PDA) [13,21,22,25,27] or mass spectrometric detector [32][33][34]. ...
... Different analytical methods have been used for the separation/determination of paracetamol [10][11][12][13], caffeine [14][15][16], and tramadol 2 of 14 hydrochloride [17,18], or even mixtures of them, such as paracetamol and caffeine [19][20][21][22][23][24] or paracetamol and tramadol hydrochloride [25][26][27][28][29][30][31]. In the majority of these works, a C 18 column for high performance liquid chromatography (HPLC) separation has been the most largely used stationary phase, together with a mobile phase mainly based on acetonitrile at acidic pH and a photodiode-array (PDA) [13,21,22,25,27] or mass spectrometric detector [32][33][34]. Moreover, simultaneous determination of paracetamol, caffeine and tramadol has been possible by gas chromatography-mass spectrometry (GC-MS) using a column Macherey-Nagel Optima 5MS Accent (30 m × 0.25 mm) and injection temperature at 270 • C [34]. ...
Article
Full-text available
Paracetamol (acetaminophen) (PAR), caffeine (CAF) and tramadol hydrochloride (TRA) are important drugs widely used for many clinical purposes. Determination of their contents is of the paramount interest. In this respect, a quick, simple and sensitive isocratic RP-HPLC method with photodiode array detection was developed for the determination of paracetamol, caffeine and tramadol in pharmaceutical formulations. An improved sensitive procedure was also evolved for tramadol using a fluorescence detector system. A C18 column and a mobile phase constituted by methanol/phosphate were used. LODs were found to be 0.2 μg/mL, 0.1 μg/mL and 0.3 μg/mL for paracetamol, caffeine and tramadol hydrochloride, respectively, using photodiode-array detection. Alternatively, LOD for tramadol decreased to 0.1 μg/mL with the fluorescence detector. Other notable analytical figures of merit include the linear concentration ranges, 0.8–270 μg/mL, 0.4–250 μg/mL and 1.0–300 (0.2–40) μg/mL, for the same ordered analytes (including the fluorescence detector). The proposed method was successfully applied for the quantitative determination of the three drugs in tablet dosage forms.
... The British Pharmacopeia suggests HPLC for the assay of capsules (8) . In literature, several spectrophotometric and chromatographic techniques were applied for its determination and analysis in various dosage forms whether it is alone or combined with other drugs as well as being analyzed in its powder form and for its quantification in plasma or biological fluids (7)(8)(9)(10)(11)(12)(13)(14)(15) . Various analytical techniques have been reported for either quantification of tramadol individually or its simultaneous quantification if combined with other drugs, especially analgesics such as paracetamol (8,9,11,13) , aceclofenac (9) , metamizole, ropivacaine, bupivacaine (15) , diclofenac sodium or muscle relaxants such as chlorzoxazone (7) . ...
... INTRODUCTION Paracetamol [N-(4-hydroxy-phenyl) acetamide] is a chemical compound and drug that is commonly used for headaches, other minor aches and pains of the management more sever pains where it gives room for additional non-steroidal anti-inflammatory drugs which have to be used at lower doses, for minimizing side effect (Chandka et al., 2013). Paracetamol (PCM) is used as analgesic and antipyretic and anti-inflammatory which is effect of paracetamol due to the inhibiting prostaglandin synthesis cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) (Kamble and Singh, 2012;Indian Pharmacopeia, 2007). Also paracetamol known as acetaminophen (USA) which is called by different trade names, including panadol, tylenol (derived from N-acetyl-paminophenol), and panadol extra among many other names (Marta and Jerzy, 2014). ...
Article
Full-text available
An accurate, simple, and sensitive indirect spectrophotometric method which proposed and developed for the determination of paracetamol in different pharmaceutical preparations. The proposed method was based on acid hydrolysis of PAR to produced p-aminophenol (PAP), PAP was diazotization with nitrite ion to form the corresponding diazonium salt, followed by coupling with histidine reagent in alkaline medium to produced azo dye that showed maximum absorbance at 430 nm. Beer's law was obeyed in the concentration rage of 10-500 µg/20 ml (i.e. 0.5-25 ppm). The molar absorpitivity and Sandell's sensitivity of the dye were. 1.118×10 4 l.mol-1 .cm-1 and 0.0135 µg.cm-2 respectively. The method successfully has been applied for the determination of PAR in pure form,and its pharmaceutical preparations (tablets, syrup and injection).
... Numerous analytical methods were reported for the determination of paracetamol in pharmaceuticals such as, Spectrophotometric, chromatographic volumetric electrochemical in addition to polarography. Because PCM is being increasingly used for therapeutic purposes, its determination and quality control are of vital importance and one of the determining techniques most frequently used in pharmaceutical analysis is UV -VIS spectrophotometry [ Figure 1, Figure 2 & Figure 3] [4][5][6]. ...
... Many methodology were found in ISSN 2249-1848 www.pharmascholars.com 471 literature for analysis of PCM; spectrophotometry [14,15], fluorimetry [16], IR [17], electrochemistry [18], chemomertry [19], HPLC [20,21], GC [22]. There are few analytical assays reported in the literature to describe a parallel analysis of both drugs in mixture. ...
Article
Full-text available
Currently the anti-emetic drug metoclopramide hydrochloride (MCP-HCl) is co-formulated with paracetamol (PCM). Three simple, economic and fast methods for determination of both drugs, simultaneously and without previous separation were developed. In first method (A), a third derivative spectrophotometric method was developed. The peaks amplitudes of third derivative spectra of MCP-HCl and PCM were measured at 334.5 and 299 nm, respectively. In second method (B), a ratio subtraction spectrophotometric method was developed. The peak amplitude of first derivative spectrum of MCP-HCl was measured at 321 nm at which PCM spectrum gives zero crossing point whereas the peak amplitude of ratio subtraction spectrum of PCM was measured at 292 nm. Both spectrophotomertric methods were linear within concentration range of MCP-HCl; 12-60 µg/mL and PCM; 35-165 µg/mL with high correlation coefficients. In third method (C), HP-TLC method was developed. The mobile phase composed of methanol, chloroform and conc. ammonia solution (10: 2: 0.15) gave typical chromatogram for MCP-HCl and PCM at R f s 0.21 ± 0.02 & 0.59 ± 0.02, respectively and the UV scanning was carried out at 270 nm. The method was linear within range of MCP-HCl; 6-18 µg/mL and PCM; 5-50 µg/mL giving high correlation coefficients. Complete validation process of the established methods was performed according to ICH guidelines and USP requirements and gave relative standard deviation values for all the key validation parameters less than 2.00%.
... Numerous analytical methods were reported for the determination of paracetamol in pharmaceuticals such as, Spectrophotometric, chromatographic volumetric electrochemical in addition to polarography. Because PCM is being increasingly used for therapeutic purposes, its determination and quality control are of vital importance and one of the determining techniques most frequently used in pharmaceutical analysis is UV -VIS spectrophotometry [ Figure 1, Figure 2 & Figure 3] [4][5][6]. ...
Article
Full-text available
The objective of the project seeks to develop an effective significant less going to consume as well as simple spectrophotometry for such assay of Mefenamic acid Paracetamol and Furosemide. Comparative of assay of 3 distinct brand products of Mefenamic acid (Meftal 250-dt, Mefacid, Mefac), Paracetamol (T-98, Parawal-500, Crocin) and Furosemide (Lasix, Frusenex, and Furosemide) available in medical store of Akkalkuwa dist-nandurbar, India has also been done. With us results reveal that between the all 3 brand products anyway of Mefac shows highest percent assay 105.48% while mefacid shows lowest value for percentage assay 95.48% and in all brands of Paracetamol Parawal-500 shows highest percent assay 106.66% T-98 shows lowest percent assay 98.66% & Furosemide Frusenex shows greatest percentage assay of 104% while Furosemide demonstrates lower critical for percentage assay 95%. The part of its success excellent reliability inside the variety of 6.25-100 µg/ml with all brands of Mefenamic acid and Furosemide to correlation coefficient of 0.999. The recovery among all brand products of Mefenamic acid, Paracetamol and Furosemide was > 90%. The dilution and assay method perform in water and NaOH as a solvent.
Article
Full-text available
A simple, precise, specific and accurate high performance thin layer chromatographic method has been developed for the simultaneous determination of Tapentadol Hydrochloride (TAPE) and Paracetamol (PCM) in pharmaceutical dosage form. The separation was carried out on Merck HPTLC aluminum plates of silica gel G60 F254, (20 × 10 cm) with 250 μm thickness using chloroform: toluene: methanol: glacial acetic acid (6: 2: 1.5: 0.5, v/v/v/v) as mobile phase. HPTLC separation of the two drugs followed by densitometric measurement was carried out in the absorbance mode at 274 nm. The drugs were resolved satisfactorily with Rf values of 0.25 ± 0.01 and 0.55 ± 0.01 for TAPE and PCM, respectively. The linear regression analysis data for the calibration plots showed good linear relationship with R2 value 0.9982 and 0.9964 for TAPE and PCM, respectively in the concentration range of 50 - 250 ng/spot for TAPE and 325 - 1625 ng ng/spot for PCM. The method was validated for accuracy, precision, specificity and robustness. The limit of detection and quantitation were 0.5067 and 1.5355 ng/spot, respectively for TAPE and 0.5706 and 1.7456 ng/spot, respectively for PCM. The proposed developed HPTLC method can be applied for identification and quantitative determination of TAPE and PCM in bulk drug and drug formulation.
Article
Full-text available
Two methods are developed for simultaneous estimation of paracetamol, domperidone and tramadol HCl in pure and tablet dosage form by using 0.1N NaOH as a solvent. Paracetamol, domperidone and tramadol HCl show absorbance maximums at 256 nm, 289.6 nm and 218.4 nm respectively. Shimadzu UV 1700, capable of multicomponent analysis, was used for quantitation. In method I, absorbance of the sample solution was measured at 256 nm and 289.6 nm for the estimation of paracetamol, domperidone respectively as tramadol HCl does not absorb at these wavelengths. Estimation of tramadol HCl was carried out at 218.4 nm. Method II is based on a multiwavelength spectroscopic method. Validation study reveals that the methods are specific, accurate, precise, and reproducible. All three drugs obey Beer's law in the concentration ranges used for the methods. Validation studies are statistically significant as all the statistical parameters are within the acceptance range (% COV< 2.0 and S.D. < 2.0) for both accuracy and precision study. High recovery and low % COV reveals the reliability of the method for quantitative study of three drugs in tablet formulation. The methods are simple, rapid accurate, precise, reproducible, and economic and can be used for routine quantitative analysis of paracetamol, domperidone and tramadol HCl in pure and tablet dosage form.
Article
Full-text available
Two simple, rapid, and selective analytical procedures were developed for the simultaneous determination of paracetamol (PR) and tramadol hydrochloride (TR) in a binary mixture using high-performance liquid chromatography with UV detection (HPLC-UV) and gas chromatography with mass spectrometry (GC-MS) techniques. HPLC resolved the two compounds on a Hypurity Advance column using a mobile phase consisting of phosphate buffer pH 6.3 and acetonitrile (90:10, v/v). PR and TR were detected by their UV absorption at 220 nm. GC-MS involved separation of the two compounds using 100% dimethylpolysiloxane (Rtx-1) column with temperature programming. The EI mass spectrum of PR was characterized by [M](+) at 151 and a base peak at m/z 109 while TR mass spectrum was characterized by [M](+) at 263 and a base peak at m/z 58. Quantification of the analytes in both methods was based on measuring the peak areas. The reliability and analytical performance of the proposed methods including linearity, ranges, precision, accuracy, detection, and quantification limits were statistically validated. Calibration curves were linear over the range 10-400 microg/mL for both PR and TR using the HPLC method and over the ranges of 75-500 and 25-350 microg/mL for PR and TR, respectively, using the GC-MS method. The proposed methods were successfully applied for the determination of the two compounds in laboratory-prepared mixtures and in commercially available tablet formulation. No interference peaks were observed from common pharmaceutical adjuvants. The results compared favorably with those obtained by a derivative spectrophotometric method.
Article
Full-text available
A derivative spectrophotometric procedure has been developed for the simultaneous determination of individual combination of aceclofenac and tramadol with paracetamol in combined tablet preparation. Tablet extracts of the drugs were prepared in distilled water. The zero crossing point technique and the compensation technique were used to estimate the amount of each drug in the combined formulations, and were compared. The results were found to be accurate and free from interferences. The procedure is rapid, simple, nondestructive, and does not require solutions of equations. Calibration graphs are linear (r=0.9999), with a zero intercept up to 24 mg/ml of each drug in combination with paracetamol. Detection limits at the p = 0.05 level of significance were calculated to be 0.5 mg/ml of aceclofenac, tramadol and paracetamol respectively.
Article
Full-text available
Two simple and sensitive visible spectrophotometric methods (A and B) have been developed for the quantitative estimation of nitazoxanide, in bulk drug and pharmaceutical dosage forms. Methods were based on the formation of reddish yellow coloured and green coloured chromogens, which were measured at 544 nm and 715 nm, respectively. The results obtained with the proposed methods are in good agreement with the labelled amounts when tablet dosage forms were analysed.
Article
A simple, fast, precise and accurate liquid chromatographic method was developed for the simultaneous estimation of paracetamol and tramadol in combined dosage forms. This combination is used as analgesic in dental and postsurgical pain. Drugs are chromatographed on a reverse phase Kromasil C18 column using a mobile phase, 0.1M Potassium dihyrdogen phosphate buffer (pH 6.8) and Methanol in the ratio of 40:60%v/v. Valdecoxib was used as an internal standard. The retention time of paracetamol, tramadol, and valdecoxib was 3.15, 5.65, 8.22 min, respectively. The validation of the proposed method was also carried out. The method was found to be linear (r>0.99), precise (%RSD: 0.49% for paracetamol and 0.89% for domperidone), accurate (overall average recovery yields: paracetamol 99.81% and domperidone 98.98%) and selective. Due to its simplicity and accuracy the proposed method can be used for routine quality control analysis of these drugs in combined dosage form.
Article
This paper presents a new reversed-phase liquid chromatographic (RPLC) method with ultraviolet absorbance diode-array detection (UV-DAD) for simultaneous determination of paracetamol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, and ethyl parahydroxybenzoate in commercial medicinal oral suspension and tablets. The chromatographic separation is achieved with acetonitrile, tetrahydrofuran, and water in a ratio of 21:13:66 (v/v/v) adjusted to pH 3 with formic acid as the mobile phase, a Lichrosorb RP8 (150 mm × 4.6 mm, 5 µm) column, and UV detection at 249 nm. The linear range of determination for paracetamol, methyl parahydroxybenzoate, propyl parahydroxybenzoate, and ethyl parahydroxybenzoate were 25–160 µg/mL, 20–128 µg/mL, 5–40 µg/mL, and 5–32 µg/mL, respectively. The correlation coefficients are ≥0.9997 for each analyte. The mean percent relative standard deviation values for intra- and interday precision studies are
Article
A simple, rapid, and validated HPLC method has been developed for determination of tramadol hydrochloride in tablet preparations. A LiChrospher 100 CN column was used with a mobile phase consisting of an acetonitrile–ion pair solution, 25 + 75, v/v. Quantitative evaluation was performed at 275 nm. The HPLC method is selective, precise, and accurate, and can be used for routine analysis of the capsule preparations in pharmaceutical industry quality control laboratories.
Article
This study presents a high-performance liquid chromatography–electrospray ionization–mass spectrometric (LC–ESI–MS) method for the simultaneous determination of tramadol and acetaminophen in human plasma using phenacetinum as the internal standard. After alkalization with saturated sodium bicarbonate, both compounds were extracted from human plasma with ethyl acetate and were separated by HPLC on a Hanbon LiChrospher CN column with a mobile phase of 10mM ammonium acetate buffer containing 0.5% formic acid–methanol (40:60, v/v) at a flow rate of 1mLmin−1. Analytes were determined using electrospray ionization in a single quadrupole mass spectrometer. LC–ESI–MS was performed in the positive selected-ion monitoring (SIM) mode using target ions at [M+H]+ m/z 264.3 for tramadol, [M+H]+ m/z 152.2 for acetaminophen and [M+H]+ m/z 180.2 for phenacetinum. Calibration curves were linear over the range of 5–600ngmL−1 for tramadol and 0.03–16μgmL−1 for acetaminophen. The inter-run relative standard deviations were less than 14.4% for tramadol and 12.3% for acetaminophen. The intra-run relative standard deviations were less than 9.3% for tramadol and 7.9% for acetaminophen. The mean plasma extraction recovery for tramadol and acetaminophen were in the ranges of 82.7–85.9 and 83.6–85.3%. The method was applied to study the pharmacokinetics of a new formulation of tramadol/acetaminophen tablet in healthy Chinese volunteers.
Article
This paper describes development and validation of a high-performance liquid chromatographic method for simultaneous analysis of tramadol hydrochloride (TR) and aceclofenac (AC) in a tablet formulation. When the combination formulation was subjected to ICH-recommended stress conditions, adequate separation of TR, AC, and the degradation products formed was achieved on a C 18 column with 65:35 ( v / v ) 0.01 M ammonium acetate buffer, pH 6.5—acetonitrile as mobile phase at a flow rate of 1 mL min −1 . UV detection was performed at 270 nm. The method was validated for specificity, linearity, LOD and LOQ, precision, accuracy, and robustness. The method was specific against placebo interference and also during forced degradation. The linearity of the method was investigated in the concentration ranges 15–60 μg mL −1 ( r = 0.9999) for TR and 40–160 μg mL −1 ( r = 0.9999) for AC. Accuracy was between 98.87 and 99.32% for TR and between 98.81 and 99.49% for AC. Because degradation products were well separated from the parent compounds, the method was stability-indicating.